Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 15Prostatic Neoplasms 12Neoplasms 11Brain Neoplasms 10Lung Neoplasms 9Glioma 9Glioblastoma 9Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Colonic Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Cancer, Papillary 2Small Cell Lung Carcinoma 2Recurrence 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neuroendocrine Tumors 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Acute 2

Interventions

Valganciclovir 1Therapeutics 1Polymerase Chain Reaction 1Magnetic Resonance Spectroscopy 1Gene-Eden-VIR 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Blood Specimen Collection 1Antiviral Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cytomegalovirus Infections × Magnetic Resonance Spectroscopy × Clear all
NCT02600065 2023-02-16

GLIO-CMV-01

University of Erlangen-Nürnberg Medical School

Completed
350 enrolled

Cytomegalovirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡